TC
MRTX

TradeLink Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

TradeLink Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-500
Closed -$10K – 398
2014
Q1 		$10K Buy
+500
New +$10.4K 0.01% 226

Other funds holding MRTX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TradeLink Capital's MRTX Position: Q2 2014 in Review

TradeLink Capital sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2014, closing a stake of 500 shares — an estimated $10K sold.

TradeLink Capital first reported a position in MRTX in Q1 2014 and held it in 1 quarter. The position peaked at $10K in Q1 2014. 44 funds tracked by Wall St. Rank hold MRTX as of Q2 2014.

  • TradeLink Capital reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • TradeLink Capital sold 500 Mirati Therapeutics, Inc. Common Stock shares in Q2 2014, an estimated $10K.
  • TradeLink Capital first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • TradeLink Capital's Mirati Therapeutics, Inc. Common Stock position peaked at $10K in Q1 2014.
  • 44 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2014.

Based on TradeLink Capital's 13F filing for Q2 2014, filed 31 Jul 2014.